• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一步法核酸扩增(OSNA)检测腹腔冲洗液中分子细胞学在晚期胃癌患者中的预后价值。

Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients.

机构信息

Department of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080, Lublin, Poland.

Department of Human Physiology, Medical University of Lublin, Radziwiłłowska 11 St., 20-080, Lublin, Poland.

出版信息

Sci Rep. 2022 Jul 21;12(1):12477. doi: 10.1038/s41598-022-16761-8.

DOI:10.1038/s41598-022-16761-8
PMID:35864130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304381/
Abstract

Peritoneal dissemination is a common form of gastric cancer (GC) recurrence, despite surgery with curative intent. This study aimed to evaluate the prognostic value of intraperitoneal lavage One-Step Nucleic Acid Amplification (OSNA) assay in advanced GC patients. OSNA assay targeting CK-19 mRNA was applied to detect free cancer cells (FCC) in intraperitoneal lavage samples obtained during gastrectomy. A total of 82 GC patients were enrolled to investigate the correlation between OSNA assay and patient's prognosis. Of the 82 patients, OSNA assay was positive in 25 (30.5%) patients. The median OS in OSNA positive patients was significantly lower than in OSNA negative patients (19 vs 45 months). Positive OSNA assay result was a significant unfavourable prognostic factor in both, univariable (HR 3.45, 95% CI 0.95-12.48; p = 0.0030) and multivariable analysis (HR 3.10, 95% CI 1.22-8.54; p = 0.0298). Positive OSNA assay in intraperitoneal lavage is a valuable indicator of poor survival in advanced GC patients after multimodal treatment. After further confirmation on larger sample size, OSNA assay of peritoneal washings could be considered an adjunct tool to conventional cytology, the current gold standard, to provide precise intraoperative staging and additional prognostic information.

摘要

尽管进行了有治愈意图的手术,但腹膜播散仍是胃癌(GC)复发的常见形式。本研究旨在评估腹腔灌洗一步法核酸扩增(OSNA)检测在晚期 GC 患者中的预后价值。该检测针对 CK-19 mRNA,用于检测胃切除术中获得的腹腔灌洗样本中的游离癌细胞(FCC)。共纳入 82 例 GC 患者,以研究 OSNA 检测与患者预后之间的相关性。在 82 例患者中,有 25 例(30.5%)OSNA 检测阳性。OSNA 阳性患者的中位 OS 明显低于 OSNA 阴性患者(19 个月 vs 45 个月)。OSNA 检测阳性结果是单变量分析(HR 3.45,95%CI 0.95-12.48;p=0.0030)和多变量分析(HR 3.10,95%CI 1.22-8.54;p=0.0298)中均为显著的不利预后因素。多模态治疗后,腹腔灌洗液中 OSNA 检测阳性是晚期 GC 患者生存不良的有价值指标。在更大的样本量上进一步确认后,腹腔冲洗液 OSNA 检测可以作为传统细胞学(目前的金标准)的辅助工具,提供精确的术中分期和额外的预后信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf2/9304381/63f191271c82/41598_2022_16761_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf2/9304381/f3380f6fbf50/41598_2022_16761_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf2/9304381/63f191271c82/41598_2022_16761_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf2/9304381/f3380f6fbf50/41598_2022_16761_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf2/9304381/63f191271c82/41598_2022_16761_Fig2_HTML.jpg

相似文献

1
Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients.一步法核酸扩增(OSNA)检测腹腔冲洗液中分子细胞学在晚期胃癌患者中的预后价值。
Sci Rep. 2022 Jul 21;12(1):12477. doi: 10.1038/s41598-022-16761-8.
2
Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients.胃癌患者术中腹腔灌洗液中游离癌细胞的一步法核酸扩增(OSNA)快速检测。
Cells. 2020 Sep 25;9(10):2168. doi: 10.3390/cells9102168.
3
Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results.进展期胃癌患者D2胃切除术中通过腹膜灌洗一步核酸扩增(OSNA)检测进行分子细胞学分析:初步结果
J Clin Med. 2021 Nov 10;10(22):5230. doi: 10.3390/jcm10225230.
4
One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer.一步法核酸扩增(OSNA)在胃癌前哨淋巴结概念中的应用。
Ann Surg Oncol. 2011 Aug;18(8):2289-96. doi: 10.1245/s10434-011-1591-9. Epub 2011 Feb 8.
5
Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter Study.一步法核酸扩增检测淋巴结阳性是 II 期结直肠癌患者术后癌症复发的预后因素:一项前瞻性、多中心研究。
Ann Surg Oncol. 2020 Apr;27(4):1077-1083. doi: 10.1245/s10434-019-07971-y. Epub 2019 Nov 13.
6
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.一步法核酸扩增技术在乳腺癌前哨淋巴结转移检测中的临床应用。
Breast Cancer. 2013 Apr;20(2):181-6. doi: 10.1007/s12282-011-0324-z. Epub 2011 Dec 28.
7
Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.一步法核酸扩增(OSNA)在检测早期宫颈癌前哨淋巴结低容量转移中的作用。
Int J Gynecol Cancer. 2020 Mar;30(3):364-371. doi: 10.1136/ijgc-2019-000939. Epub 2020 Jan 23.
8
Intraoperative molecular assessment for lymph node metastasis in head and neck squamous cell carcinoma using one-step nucleic acid amplification (OSNA) assay.一步法核酸扩增(OSNA)检测用于头颈部鳞状细胞癌淋巴结转移的术中分子评估。
Ann Surg Oncol. 2012 Nov;19(12):3865-70. doi: 10.1245/s10434-012-2409-0. Epub 2012 May 23.
9
One-step nucleic acid amplification (OSNA): where do we go with it?一步核酸扩增(OSNA):我们将何去何从?
Int J Clin Oncol. 2017 Feb;22(1):3-10. doi: 10.1007/s10147-016-1030-9. Epub 2016 Aug 22.
10
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison.标准超分期与一步法核酸扩增在子宫内膜癌患者前哨淋巴结转移检测中的比较:一项回顾性队列比较。
Int J Gynecol Cancer. 2020 Mar;30(3):372-377. doi: 10.1136/ijgc-2019-000937. Epub 2020 Jan 28.

引用本文的文献

1
Gastric Cancer (GC) with Peritoneal Metastases (PMs): An Overview of Italian PSM Oncoteam Evidence and Study Purposes.伴有腹膜转移(PMs)的胃癌(GC):意大利PSM肿瘤治疗团队的证据及研究目的概述
Cancers (Basel). 2023 Jun 10;15(12):3137. doi: 10.3390/cancers15123137.

本文引用的文献

1
Clinical Significance of Peritoneal Fluid Examination for Free Cancer Cells in Patients Qualified for Surgery for Gastric Cancer.胃癌手术患者腹腔积液游离癌细胞检查的临床意义
Front Surg. 2021 Jun 21;8:685868. doi: 10.3389/fsurg.2021.685868. eCollection 2021.
2
Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients.胃癌患者术中腹腔灌洗液中游离癌细胞的一步法核酸扩增(OSNA)快速检测。
Cells. 2020 Sep 25;9(10):2168. doi: 10.3390/cells9102168.
3
Free cancer cells in gastric cancer - methods of detection, clinical and prognostic importance (meta-analysis).
胃癌中的游离癌细胞——检测方法、临床及预后意义(荟萃分析)
Contemp Oncol (Pozn). 2020;24(1):67-74. doi: 10.5114/wo.2020.94724. Epub 2020 Mar 30.
4
Japanese gastric cancer treatment guidelines 2018 (5th edition).《日本胃癌治疗指南2018(第5版)》
Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.
5
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.紫杉醇腹腔内和静脉给药联合 S-1 对比顺铂联合 S-1 治疗胃癌伴腹膜转移患者的 III 期临床试验:PHOENIX-GC 试验。
J Clin Oncol. 2018 Jul 1;36(19):1922-1929. doi: 10.1200/JCO.2018.77.8613. Epub 2018 May 10.
8
The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients.第八版美国癌症联合委员会胃癌肿瘤-淋巴结-转移分期系统优于第七版:来自中国单机构 1663 例患者的研究结果。
Gastric Cancer. 2018 Jul;21(4):643-652. doi: 10.1007/s10120-017-0779-5. Epub 2017 Nov 22.
9
Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.腹腔镜高温腹腔内热灌注化疗治疗胃腺癌腹膜转移或阳性腹腔细胞学患者的 II 期临床试验。
Ann Surg Oncol. 2017 Oct;24(11):3338-3344. doi: 10.1245/s10434-017-6047-4. Epub 2017 Aug 10.
10
Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.腹腔灌洗细胞学检查对胃癌分期的预后意义:系统评价和荟萃分析。
Gastric Cancer. 2018 Jan;21(1):10-18. doi: 10.1007/s10120-017-0749-y. Epub 2017 Aug 4.